Miorelax en es it fr

Miorelax Brand names, Miorelax Analogs

Miorelax Brand Names Mixture

  • No information avaliable

Miorelax Chemical_Formula


Miorelax RX_link


Miorelax fda sheet

Miorelax FDA

Miorelax msds (material safety sheet)

Miorelax MSDS

Miorelax Synthesis Reference

No information avaliable

Miorelax Molecular Weight

198.216 g/mol

Miorelax Melting Point

78.5 oC

Miorelax H2O Solubility

50 mg/mL

Miorelax State


Miorelax LogP


Miorelax Dosage Forms

Liquid; Powder for solution; Syrup; Tablet

Miorelax Indication

Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections.

Miorelax Pharmacology

Guaifenesin is an expectorant which increases the output of phlegm (sputum) and bronchial secretions by reducing adhesiveness and surface tension. The increased flow of less viscous secretions promotes ciliary action and changes a dry, unproductive cough to one that is more productive and less frequent. By reducing the viscosity and adhesiveness of secretions, guaifenesin increases the efficacy of the mucociliary mechanism in removing accumulated secretions from the upper and lower airway.

Miorelax Absorption

Rapidly absorbed from the GI tract

Miorelax side effects and Toxicity

LD50 1510 mg/kg (rat, oral)

Miorelax Patient Information

No information avaliable

Miorelax Organisms Affected

Humans and other mammals